ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
CONMED Corporation

CONMED Corporation (CNMD)

101,41
0,00
(0,00%)
Fermé 30 Novembre 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
101,41
Prix Achat
100,00
Prix Vente
106,01
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
Clôture Veille
101,41
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
30 752 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
48,38
Bénéfice par action (BPA)
2,1
Chiffre d'affairess
1,24B
Bénéfice net
64,46M

À propos de CONMED Corporation

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. ce... Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for 52% of revenue, EMEA accounting for 19%, APAC at 17%, and the non-U.S. Americas region driving the remaining 12%. Show more

Secteur
Electromedical Apparatus
Industrie
Electromedical Apparatus
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-

CNMD Dernières nouvelles

CONMED Corporation to Transfer Listing of Common Stock to the New York Stock Exchange

CONMED Corporation (NASDAQ: CNMD) today announced that it is transferring the listing of its common stock to the New York Stock Exchange (NYSE) from the NASDAQ Global Market. CONMED expects to...

CONMED Corporation Announces Fourth Quarter and Full-Year 2019 Financial Results

CONMED Corporation (Nasdaq: CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2019. Fourth Quarter 2019 Highlights Sales of $264.9 million increased...

CONMED Corporation to Announce Fourth Quarter and Full-Year 2019 Financial Results on January 29, 2020

CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the fourth quarter and full year 2019 after the market close on Wednesday, January 29, 2020. The...

CONMED Corporation to Present at the J.P. Morgan Healthcare Conference

CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will...

CONMED Corporation Announces Quarterly Cash Dividend

CONMED Corporation (NASDAQ: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on January 7, 2020 to all shareholders of record...

CONMED Corporation to Present at the Jefferies London Healthcare Conference

CONMED Corporation (NASDAQ: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Jefferies London Healthcare Conference at 9:20...

CONMED Corporation Announces Third Quarter 2019 Financial Results

CONMED Corporation (Nasdaq: CNMD) today announced financial results for the third quarter of 2019. Third Quarter 2019 Highlights Sales of $233.6 million increased 15.5% year over year as reported...

CONMED Corporation to Announce Third Quarter 2019 Financial Results on October 30, 2019

CONMED Corporation (NASDAQ:CNMD) today announced that it will report financial results for the third quarter of 2019 after the market close on Wednesday, October 30, 2019. The Company’s...

CONMED Corporation Adds LaVerne Council and Barbara Schwarzentraub to its Board of Directors

CONMED Corporation (NASDAQ: CNMD) announced today that LaVerne Council and Barbara Schwarzentraub are joining its Board of Directors. Ms. Schwarzentraub will join the Board effective immediately...

CONMED Corporation to Present at the Morgan Stanley Global Healthcare Conference

CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
BSLKBolt Projects Holdings Inc
US$ 0,71
(139,86%)
80,07M
PRZOParaZero Technologies Ltd
US$ 1,24
(94,14%)
202,48M
AIEVThunder Power Holdings Inc
US$ 0,47
(87,25%)
122,71M
PASGPassage Bio Inc
US$ 1,13
(69,52%)
15,43M
EPOWSunrise New Energy Company Ltd
US$ 1,06
(45,21%)
314,9k
APLTApplied Therapeutics Inc
US$ 2,03
(-76,31%)
42,74M
TGLTreasure Global Inc
US$ 0,2944
(-29,08%)
1,83M
PROCProcaps Group SA
US$ 1,51
(-27,75%)
98,71k
SHOTWSafety Shot Inc
US$ 0,104
(-20,00%)
1,43k
MONDMondee Holdings Inc
US$ 0,7102
(-19,59%)
297,61k
PRZOParaZero Technologies Ltd
US$ 1,24
(94,14%)
205,02M
NVDANVIDIA Corporation
US$ 138,25
(2,15%)
141,86M
AIEVThunder Power Holdings Inc
US$ 0,47
(87,25%)
122,71M
RGTIRigetti Computing Inc
US$ 3,05
(27,08%)
116,98M
MARAMARA Holdings Inc
US$ 27,42
(1,86%)
89,54M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées